Compile Data Set for Download or QSAR
Report error Found 680 of affinity data for UniProtKB/TrEMBL: Q96RG2
LigandPNGBDBM50652792(CHEMBL3752910)
Affinity DataKd:  1.35E+4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
LigandPNGBDBM130909(US8822500, Stauro- sporine | US9920060, Staurospor...)
Affinity DataIC50: 1.60nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 5.5nMAssay Description:Inhibition of human PASK using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details Article
PubMed
LigandPNGBDBM2579(CHEMBL388978 | Staurosporine, 8 | Staurosporin, 4 ...)
Affinity DataIC50: 15.8nMAssay Description:Inhibition of human PASK using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
LigandPNGBDBM50154943(CHEMBL3775576)
Affinity DataIC50: 260nMAssay Description:Inhibition of PASK (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/9/2017
Entry Details Article
PubMed
LigandPNGBDBM463442(3-(4-(4-Methoxyphenyl)piperidin-1-yl)-2-phenylquin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463448(3-Morpholino-2-phenylquinoxaline-6-carboxylic acid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463449(3-(4-Methyl-1,4-diazepan-1-yl)-2-phenylquinoxaline...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463450(3-(Isopropylamino)-2-phenylquinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463451(2-Phenyl-3-(4-(pyrimidin-2-yl)piperazin-1-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463452(2-Phenyl-3-(4-(5-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463453(2-phenyl-3-(4-(quinolin-2-yl)piperazin-1-yl)quinox...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463454(2-(Azepan-1-yl)-3-phenylquinoxaline-6-carboxylic a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463455(3-Phenyl-2-(piperidin-1-yl)quinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463456(2-(4-(4-Chlorophenyl)piperidin-1-yl)-3-(4-fluoroph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463457(2-(4-(3-Chlorophenyl)piperidin-1-yl)-3-(4-fluoroph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463458(3-(4-Fluorophenyl)-2-(4-(4-methoxyphenyl)piperidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463459(3-(4-Fluorophenyl)-2-(4-(pyridin-2-yl)piperazin-1-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463460(2-Phenyl-3-(4-(3-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463461(3-(4-Fluorophenyl)-2-(4-(4-(trifluoromethyl)phenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463462(2,3-Bis(4-phenylpiperidin-1-yl)quinoxaline-6-carbo...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463463(2,3-Bis(4-methoxyphenyl)-6-(1H-tetrazol-5-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463464(2-Phenyl-3-(4-(4-(trifluoromethyl)phenyl)piperazin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463465(2-Phenyl-3-(4-(pyridin-2-yl)piperazin-1-yl)quinoxa...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463466(3-(4-(3-Chlorophenyl)piperazin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463467(3-(4-Methylpiperazin-1-yl)-2-phenylquinoxaline-6-c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463468(2-Phenyl-3-(piperazin-1-yl)quinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463469(2-Phenyl-3-(4-phenylpiperazin-1-yl)quinoxaline-6-c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463470(2-Phenyl-3-(4-(4-(trifluoromethyl)phenyl)piperidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463471(3-(4-(4-Chlorophenyl)piperazin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463472(3-(4-(4-Methoxyphenyl)piperazin-1-yl)-2-phenylquin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463473(3-(4-(3-Chlorophenyl)piperidin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463474(2-Phenyl-3-(piperidin-1-yl)quinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463475(2-Phenyl-3-(4-phenylpiperidin-1-yl)quinoxaline-6-c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463476(3-(Azepan-1-yl)-2-phenylquinoxaline-6-carboxylic a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463477(3-(4-(4-Chlorophenyl)piperidin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463448(3-Morpholino-2-phenylquinoxaline-6-carboxylic acid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463449(3-(4-Methyl-1,4-diazepan-1-yl)-2-phenylquinoxaline...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463450(3-(Isopropylamino)-2-phenylquinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463451(2-Phenyl-3-(4-(pyrimidin-2-yl)piperazin-1-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463452(2-Phenyl-3-(4-(5-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463453(2-phenyl-3-(4-(quinolin-2-yl)piperazin-1-yl)quinox...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463456(2-(4-(4-Chlorophenyl)piperidin-1-yl)-3-(4-fluoroph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463458(3-(4-Fluorophenyl)-2-(4-(4-methoxyphenyl)piperidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463460(2-Phenyl-3-(4-(3-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463461(3-(4-Fluorophenyl)-2-(4-(4-(trifluoromethyl)phenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463462(2,3-Bis(4-phenylpiperidin-1-yl)quinoxaline-6-carbo...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463463(2,3-Bis(4-methoxyphenyl)-6-(1H-tetrazol-5-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463478(3-(4-(N-Methylmethan-3-ylsulfonamido)piperidin-1-y...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463479(3-(3,4-Dihydroquinolin-1(2H)-yl)-2-phenylquinoxali...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

Displayed 1 to 50 (of 680 total ) | Next | Last >>
Jump to: